Incorrect Placement of Boxes in Figure 1 and Addition of a Primary Investigator

No authors listed

Published Erratum

No authors listed. JAMA. 2022.

. 2022 Mar 22;327(12):1188.

doi: 10.1001/jama.2022.3496.

No abstract available

Erratum for

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S; Kids-DOTT Trial Investigators and the ATLAS Group. Goldenberg NA, et al. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182. JAMA. 2022. PMID: 35015038 Free PMC article. Clinical Trial.

1. Goldenberg NA, Kittelson JM, Abshire TC, et al. ; Kids-DOTT Trial Investigators and the ATLAS Group . Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial. JAMA. 2022;327(2):129-137. - PMC - PubMed